Interventional procedure overview of Balloon cryoablation for treating Barrett's oesophagus

ESGE recommend endoscopic eradication therapy using ablation for LGD and endoscopic ablation treatment for HGD. ESGE recommend offering complete eradication of all remaining BE by ablation after endoscopic resection of visible abnormalities containing any degree of dysplasia or oesophageal adenocarcinoma (EAC). Regarding the preferred method of ablation, RFA is most extensively studied and has been proved to be safe and effective. Alternative treatment methods include argon plasma coagulation, hybrid argon plasma coagulation, and cryoablation (cryoballoon and cryospray).

Endoscopic ablative therapy is recommended for patients with BE and high-grade dysplasia. Endoscopic ablative therapy is also recommended for patients with BE and low-grade dysplasia, although endoscopic surveillance continues to be an acceptable alternative. RFA is currently the preferred endoscopic ablative therapy.